Not applicableStudy completedNCT02842229
What this trial is testing
Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Who this might be right for
Myelodysplastic SyndromesLeukemia Myeloid AcuteMultiple Myeloma+1 more
Celgene 117